|
2024
|
Invention
|
Products and compositions.
Nucleic acid products are provided that modulate, in particular inter... |
|
|
Invention
|
Compositions and methods for treatment of cancers using modified sirna-gem agents.
Pharmaceutica... |
|
|
Invention
|
Oligonucleotide constructs with improved function and therapeutics. Divalent RNA molecules contai... |
|
|
Invention
|
Products and compositions. Nucleic acid products that modulate, interfere with, or inhibit TMPRSS... |
|
|
Invention
|
Products and compositions. Nucleic acid products that modulate, interfere with, or inhibit A1 AT ... |
|
|
Invention
|
Products and compositions. Nucleic acid products that modulate, interfere with, or inhibit ATS ge... |
|
|
Invention
|
Products and compositions. Nucleic acid products that modulate, interfere with, or inhibit ANGPTL... |
|
|
Invention
|
Products and compositions. Nucleic acid products that modulate, interfere with, or inhibit HSD17B... |
|
|
Invention
|
Products and compositions. Nucleic acid products that modulate, interfere with, or inhibit PCSK9 ... |
|
2023
|
Invention
|
Products and compositions. Nucleic acid products are provided that interfere with or inhibit APOC... |
|
|
Invention
|
Products and compositions. Provided are products, and compositions, and their uses. In particular... |
|
|
Invention
|
Sirnas against kras and raf1.
siRNA molecules and pharmaceutical compositions containing siRNA m... |
|
|
Invention
|
Sirnas against kras and raf1. siRNA molecules and pharmaceutical compositions containing siRNA mo... |
|
|
Invention
|
Products and compositions. Nucleic acid products, compositions and related methods of use are pro... |
|
|
Invention
|
Products and compositions. Nucleic acid products are provided that modulate, in particular interf... |
|
|
Invention
|
Combination sirna and peptide docking vehicle (pdov) compositions and methods of their use for i... |
|
|
Invention
|
Combination sirna and peptide docking vehicle (pdov) compositions and methods of their use for im... |
|
|
Invention
|
Compositions and methods for treatment of skin cancers.
siRNA sequences for inhibiting TGFβ and ... |
|
|
Invention
|
Methods for inducing adipose tissue remodeling using rnai therapeutics.
Methods are provided for... |
|
|
Invention
|
Products and compositions. The present disclosure relates to products, and compositions, and thei... |
|
|
Invention
|
Compositions and methods for treatment of cancers using modified sirna-gem agents. Pharmaceutical... |
|
|
Invention
|
Nucleoside containing sirnas for treating viral diseases.
Oligonucleotides, including siRNA dupl... |
|
|
Invention
|
Compositions and methods for inhibiting expression of pcsk9.
Double stranded RNAi agents for inh... |
|
|
Invention
|
Composition and use of sirnas against vegfr2 and tgf-beta1 in combination therapy for cancer.
Th... |
|
|
Invention
|
Targeted nucleic acid therapy for hepatitis b.
Pharmaceutical constructs containing a Peptide Do... |
|
|
Invention
|
Methods for prophylactic and therapeutic treatment of 2019-ncov using sirnas against orf1ab and n... |
|
|
Invention
|
Products and compositions.
Nucleic acid products that modulate, interfere with, or inhibit PCSK9... |
|
|
Invention
|
Methods for prophylactic and therapeutic treatment of 2019-ncov using sirnas against tgfb1 and co... |
|
2022
|
Invention
|
Methods for inducing adipose tissue remodeling using rnai therapeutics. Methods are provided for ... |
|
|
Invention
|
Treatment of 2019-ncov using sirnas against tgfb1 and cox2. Methods are provided for prevention a... |
|
|
Invention
|
Nanoparticle pharmaceutical compositions with reduced nanoparticle size and improved polydispersi... |
|
|
Invention
|
Methods for preparing nanoparticle compositions containing histidine-lysine copolymers.
Improved... |
|
|
Invention
|
Nanoparticle formulations formed from histidine-lysine copolymers.
Methods are provided for impr... |
|
|
Invention
|
Improved methods for preparing nanoparticle compositions containing histidine-lysine copolymers. ... |
|
|
Invention
|
Improved nanoparticle formulations formed from histidine-lysine copolymers. Methods are provided ... |
|
|
Invention
|
Sirna-copolymer compositions and methods of use for treatment of liver cancer.
Compositions and ... |
|
|
Invention
|
Products and compositions.
Nucleic acid products that modulate, in particular interfere with or ... |
|
|
Invention
|
Products and compositions. Nucleic acid products that modulate, in particular interfere with or i... |
|
|
Invention
|
Composition and use of sirnas against vegfr2 and tgf-beta1 in combination therapy for cancer. The... |
|
|
Invention
|
Sirna-copolymer compositions and methods of use for treatment of liver cancer. Compositions and m... |
|
|
Invention
|
Products and compositions.
Nucleic acid products and compositions and their uses are provided. I... |
|
|
Invention
|
Products and compositions. Nucleic acid products and compositions and their uses are provided. In... |
|
|
Invention
|
Products and compositions.
Nucleic acid products are provided that modulate, interfere with or i... |
|
|
Invention
|
Nucleic acid-polypeptide nano-pharmaceutical compostion for treating and preventing human papillo... |
|
|
Invention
|
Methods of cancer treatment by delivery of sirnas against nsd3.
Compositions and methods are pro... |
|
2021
|
G/S
|
Drug delivery agents in the form of a coating for nanoparticle polymers that facilitate the deliv... |
